10 ECG Rhythm questions from the ICU Basics bank. Tap an answer to see whether you were right, with a rationale for every choice. Your score is at the end.
A patient with ischemic cardiomyopathy (EF 20%) develops AF with a ventricular rate of 148, BP 104/66, and mild pulmonary congestion. Which rate-control agent is MOST appropriate?
IV amiodarone or digoxin
IV metoprolol 5 mg push
Adenosine 6 mg rapid IV push
IV diltiazem bolus and infusion
Show the answer and rationale
Answer: A
A.Correct. In AF with decompensated HFrEF, amiodarone or digoxin controls rate without the negative inotropy of diltiazem.
B. IV β-blockers are negative inotropes and, like diltiazem, are avoided in decompensated HFrEF, where they can worsen congestion and precipitate cardiogenic shock.
C. Adenosine does not convert AF, and rate slowing lasts only seconds.
D. Non-dihydropyridine CCBs are negative inotropes and are avoided in decompensated HFrEF.
For stable AF with rapid ventricular response, rate control options include β-blockers, non-dihydropyridine calcium channel blockers (diltiazem), digoxin, and amiodarone. Diltiazem and IV β-blockers are avoided or used cautiously in decompensated heart failure with reduced EF. Amiodarone and digoxin are preferred in that setting. Stroke prevention (anticoagulation) and triggers (sepsis, hypovolemia, electrolytes, pain) are addressed. Unstable patients need synchronized cardioversion.
On a telemetry unit, the central monitor alarms for VF on a 58-year-old's lead II. The nurse finds him sitting up and brushing his teeth vigorously; he answers questions and has a strong radial pulse. The pulse oximeter shows a regular waveform at 76/min. What should the nurse do NEXT?
Apply defibrillation pads in case the rhythm is real
Check the electrodes and view a second lead
Activate the code team for a VF arrest
Silence the alarm and note it as a false alarm
Show the answer and rationale
Answer: B
A. VF produces no cardiac output, so a talking patient with a strong pulse is not in VF; pads add nothing while the monitoring problem goes unfixed.
B.Correct. Movement artifact can mimic VF; checking electrode contact and another lead confirms the real rhythm and restores reliable monitoring.
C. The alarm label is tempting, but a code team is called for a patient who is unresponsive without normal breathing or a pulse, and this patient is perfusing.
D. The alarm is false, but silencing it without fixing the signal leaves the patient effectively unmonitored until someone notices.
VF is a pulseless rhythm: the ventricles quiver without contracting, so a patient in true VF is unresponsive with no pulse, and the adult cardiac arrest algorithm begins only after unresponsiveness and absent normal breathing or pulse are recognized. A responsive patient with a strong pulse and a regular oximeter waveform has a perfusing rhythm, so a chaotic trace during vigorous movement is artifact from muscle activity or electrode motion. The monitor still has to be fixed, because the next alarm may be real: checking electrode contact and viewing another lead confirms the underlying rhythm and restores reliable surveillance.
A 34-year-old marathon runner admitted after an ankle fracture has a monitor alarm for sinus bradycardia at 44/min while asleep. He wakes easily, denies dizziness or chest pain, and has BP 118/70 and warm skin. What is the MOST appropriate response?
Give atropine 0.5 mg IV to bring the rate above 50/min
Observe, continue monitoring and review any medications he takes
Request a cardiology consult for temporary transvenous pacing
Place pacing pads on the chest as a precaution against asystole
Show the answer and rationale
Answer: B
A. Atropine is for bradycardia with cardiopulmonary compromise; treating a number in an asymptomatic patient adds side effects without benefit, and 0.5 mg is also an outdated dose.
B.Correct. Without hypotension, altered mental status, shock, ischemic pain or heart failure, the algorithm directs observation and a search for causes.
C. Transvenous pacing is for persistent unstable bradycardia refractory to medical therapy, which this patient does not have.
D. Pads are applied when bradycardia is unstable or high-degree AV block threatens; sinus bradycardia in a trained athlete at rest does not warrant them.
The adult bradycardia algorithm first asks whether the rate is appropriate for the clinical condition (a bradyarrhythmia is typically below 50/min) and then whether there is cardiopulmonary compromise: hypotension, acutely altered mental status, signs of shock, ischemic chest discomfort or acute heart failure. If not, the team supports the ABCs, obtains a 12-lead ECG, looks for underlying causes and observes. A slow resting rate is common in endurance athletes and during sleep, so a well-perfused, asymptomatic runner needs no drug or pacing.
The day after catheter ablation for paroxysmal atrial fibrillation, a patient in sinus rhythm with a CHA₂DS₂-VASc score of 3 says, "Now that my AF is fixed, I can stop taking apixaban." The nurse should explain that apixaban
is replaced by aspirin while sinus rhythm holds.
can stop if a 24-hour monitor shows no AF.
continues at least 3 months after ablation.
is needed until the groin sites have healed.
Show the answer and rationale
Answer: C
A. Tempting because aspirin feels like a gentler step down, but aspirin does not prevent AF-related stroke and does not replace an anticoagulant here.
B. Tempting because it sounds evidence based, but a clear monitor does not remove the early post-ablation stroke risk or the patient's underlying risk.
C.Correct. Oral anticoagulation is continued for at least 3 months after AF ablation, and longer-term use then follows stroke risk.
D. Tempting because access-site bleeding is the visible concern after the procedure, but the reason to continue is atrial stunning and thrombus risk, not wound healing.
Ablation injures and stuns atrial tissue, and stroke risk is raised in the first weeks, about 0.8% in the first 30 days. The 2023 AF guideline therefore recommends (Class 1) continuing oral anticoagulation for at least 3 months after catheter ablation, with longer-term therapy decided by stroke risk rather than by rhythm. With a CHA₂DS₂-VASc of 3 this patient will likely stay on it, because AF can recur silently and successful ablation has not been shown to remove the need for anticoagulation.
Ibutilide is ordered to chemically convert recent-onset atrial flutter in a patient with normal EF. The baseline QTc is 430 ms, K⁺ 3.4 mEq/L, and Mg²⁺ 1.6 mg/dL. Which nursing action is MOST important?
Correct K⁺ and Mg²⁺ first, then monitor the ECG at least 4 hours
Hold all anticoagulation during the conversion to prevent bleeding
Give ibutilide by rapid IV push to speed conversion
Give the ibutilide now and check vital signs every hour
Show the answer and rationale
Answer: A
A.Correct. Ibutilide can cause torsades de pointes, and low potassium or magnesium increases the risk.
B. Anticoagulation principles for cardioversion apply to chemical conversion too.
C. It is infused over about 10 minutes, and rapid delivery increases toxicity.
D. Hourly checks without continuous monitoring can miss torsades.
Ibutilide is a class III antiarrhythmic that converts atrial flutter more effectively than AF. It prolongs the QT and causes polymorphic VT or torsades in a few percent of patients, usually within the first hours. Before infusion, potassium and magnesium are corrected (many protocols give magnesium routinely); a defibrillator is at the bedside; and continuous ECG monitoring continues for at least 4 hours or until the QTc returns to baseline.
A patient in atrial fibrillation at about 100/min has a single wide QRS beat with a right bundle branch block pattern. It ends a short R-R interval that follows an unusually long one, and no compensatory pause follows it. BP is 122/74 mm Hg, and the patient has no symptoms. This beat is MOST consistent with
a run of nonsustained ventricular tachycardia.
a premature ventricular complex.
aberrant conduction (Ashman beat).
intermittent ventricular pre-excitation.
Show the answer and rationale
Answer: C
A. One isolated beat is not a run, and the patient is stable with a supraventricular rhythm.
B. A PVC is the usual mistake, but it typically has a compensatory pause and no link to a long-short cycle.
C.Correct. A long cycle lengthens the next refractory period, so an early beat that follows finds the right bundle still refractory and conducts with RBBB aberrancy.
D. Pre-excitation widens the QRS with a delta wave and is not tied to the preceding cycle length.
Ashman phenomenon is physiologic aberrant ventricular conduction caused by a change in cycle length, most often seen in atrial fibrillation. Because refractoriness lengthens after a long R-R interval, a beat arriving after a short interval finds part of the conduction system still refractory; the right bundle has the longer refractory period, so right bundle branch block morphology is typical. The Fisch criteria are a long preceding cycle, RBBB-type aberrancy with a normal initial vector, irregular coupling and no full compensatory pause. Recognizing it matters because a PVC or ventricular tachycardia carries a different prognosis and treatment.
A 70-year-old who takes aspirin with extended-release dipyridamole for stroke prevention has a stable regular narrow-complex tachycardia at 180. Vagal maneuvers fail. The order set lists adenosine 6 mg rapid IV push, then 12 mg if needed. Which response to the order is BEST?
Ask for 12 mg as the first dose because aspirin blunts adenosine
Push the 6 mg over 1 minute to soften the response
Give 6 mg as written, since dipyridamole acts on platelets
Ask whether a smaller first dose should be given
Show the answer and rationale
Answer: D
A. Aspirin has no listed interaction with adenosine; the drug in this combination that matters is dipyridamole, and it strengthens rather than blunts the effect.
B. A slow push does not make a safer dose; adenosine is cleared within seconds, so a slow injection may simply fail while the interaction remains.
C. Dipyridamole is used as an antiplatelet agent, but it also blocks the cellular uptake that clears adenosine, which is why the label warns of a stronger effect.
D.Correct. Dipyridamole blocks the nucleoside transport that clears adenosine and so potentiates it; the label notes that smaller doses may be effective, while a standard dose risks a longer pause or block.
Adenosine is cleared from the blood within seconds by uptake into red cells and vessel walls through a nucleoside transporter. Dipyridamole blocks that transporter, so the same dose acts more strongly, and the label states that smaller doses may be effective; carbamazepine can also deepen the AV block adenosine produces, while methylxanthines act the other way. The label gives no reduced figure, so the first dose follows the prescriber or local protocol, with a defibrillator and pacing ready because heart block and prolonged asystole can occur.
A 67-year-old with atrial fibrillation at 168/min, BP 74/40 and new confusion receives a synchronized 200-J shock under sedation. Seconds later the monitor shows VF, and no carotid pulse is felt. The nurse presses SHOCK again at 200 J, but the device does not discharge, and the SYNC indicator is still lit. What should be done NEXT?
Keep pressing SHOCK until the device senses an R wave
Start CPR for 2 minutes, then shock at the next check
Give epinephrine 1 mg IV, then repeat the same shock
Turn off sync and deliver an unsynchronized shock
Show the answer and rationale
Answer: D
A. In sync mode the device waits for an R wave to time the discharge. VF has no organized QRS, so holding the button can waste critical seconds without any shock being delivered.
B. CPR while a shock is prepared is right in many arrests, which makes this tempting, but this VF is witnessed and monitored with pads already on. A prompt shock is the priority, and a 2-minute delay lowers the chance of terminating it.
C. In shockable arrest, epinephrine follows failed initial defibrillation attempts. No defibrillation has yet been delivered for this VF, and a repeat attempt with sync still on would fail the same way.
D.Correct. VF has no R wave for the device to sense, so sync is switched off and the patient is defibrillated at once, with CPR resumed right after the shock.
Synchronized cardioversion times the shock to the R wave so the energy does not land on the T wave, the vulnerable period in which a shock can induce VF. The 2023 AF guideline therefore asks teams to switch sync on, or confirm it, before each shock, because devices differ in whether sync stays on after a discharge. Once the rhythm degenerates to VF or polymorphic VT there is no QRS to sense, so a device left in sync mode may never fire. Sync is switched off, an unsynchronized defibrillation is delivered immediately, and compressions restart right after it.
A patient admitted for syncope has a 12-lead ECG showing sinus rhythm with a QTc of 540 ms. Which medication on the home list should the nurse question FIRST?
Lisinopril 10 mg once daily in the morning
Atorvastatin 40 mg nightly at bedtime
Ondansetron 8 mg every 8 hours as needed
Metoprolol succinate 50 mg once daily in the morning
Show the answer and rationale
Answer: C
A. ACE inhibitors do not affect the QT interval.
B. Statins have no effect on repolarization.
C.Correct. Ondansetron prolongs the QT interval and, combined with an already prolonged QTc, raises the risk of torsades, the likely cause of syncope.
D. Beta-blockers do not prolong the QT interval and are protective in congenital long QT.
Syncope with a QTc over 500 ms suggests torsades de pointes as the mechanism. The nurse should identify and stop QT-prolonging drugs (ondansetron, many antiemetics, antipsychotics, fluoroquinolones, macrolides, methadone), correct potassium and magnesium, and keep the patient on continuous monitoring with a defibrillator nearby.
Dofetilide 500 mcg by mouth twice daily is ordered for a 78-year-old woman with persistent atrial fibrillation who weighs 60 kg. Serum creatinine is 1.5 mg/dL, QTc is 420 ms, and K⁺ and Mg²⁺ are normal. Which action should the nurse take?
hold it; a clearance under 40 rules it out.
question the dose; 250 mcg twice daily fits.
question the dose; 125 mcg twice daily fits.
give it; the QTc and electrolytes are acceptable.
Show the answer and rationale
Answer: C
A. Tempting because the clearance is low, but dofetilide is contraindicated below 20 mL/min; at 20 to 40 it is given at a reduced dose.
B. Tempting because some reduction is clearly needed, but 250 mcg twice daily is the dose for a creatinine clearance of 40 to 60 mL/min.
C.Correct. Her calculated creatinine clearance is about 29 mL/min, and the label's starting dose for 20 to under 40 mL/min is 125 mcg twice daily.
D. Tempting because the QTc is below 440 ms and electrolytes are normal, but the starting dose is set by creatinine clearance, which is low here.
Dofetilide is renally cleared and causes dose-related QT prolongation and torsades de pointes, so the label sets the starting dose by Cockcroft-Gault creatinine clearance: (140 − 78) × 60 ÷ (72 × 1.5) × 0.85 ≈ 29 mL/min for this woman, which falls in the 20 to under 40 band (125 mcg twice daily). Initiation requires at least 3 days in a facility with continuous ECG monitoring, the QTc is measured 2 to 3 hours after each dose, and the dose is lowered if the QTc rises more than 15% or above 500 ms. Interacting drugs such as verapamil, hydrochlorothiazide and trimethoprim are contraindicated.
These 10 are a sample. ICU Basics has 105 ECG Rhythm questions, and it keeps your score, explains every choice and brings back the ones you miss. No ads. Pro is coming in January 2027.